Stock Research for EXEL

EXEL

Featured Broker: Ally Invest

Get the due diligence for another stock.

 

EXEL Stock Chart & Research Data

The EXEL chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the EXEL chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


 


EXEL Due diligence Resources & Stock Charts

The EXEL stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View EXEL Detailed Price Forecast - CNN Money CNN View EXEL Detailed Summary - Google Finance
Yahoo View EXEL Detailed Summary - Yahoo! Finance Zacks View EXEL Stock Research & Analysis - Zacks.com

Stock Analysis

TradeIdeas View EXEL Trends & Analysis - Trade-Ideas Barrons View EXEL Major Holders - Barrons
NASDAQ View EXEL Call Transcripts - NASDAQ Seeking View EXEL Breaking News & Analysis - Seeking Alpha
Spotlight View EXEL Annual Report - CompanySpotlight.com OTC Report View EXEL OTC Short Report - OTCShortReport.com
TradeKing View EXEL Fundamentals - TradeKing Charts View EXEL SEC Filings - Bar Chart
WSJ View Historical Prices for EXEL - The WSJ Morningstar View Performance/Total Return for EXEL - Morningstar
MarketWatch View the Analyst Estimates for EXEL - MarketWatch CNBC View the Earnings History for EXEL - CNBC
StockMarketWatch View the EXEL Earnings - StockMarketWatch MacroAxis View EXEL Buy or Sell Recommendations - MacroAxis
Bullish View the EXEL Bullish Patterns - American Bulls Short Pains View EXEL Short Pain Metrics - ShortPainBot.com

Social Media Mentions

StockTwits View EXEL Stock Mentions - StockTwits PennyStocks View EXEL Stock Mentions - PennyStockTweets
Twitter View EXEL Stock Mentions - Twitter Invest Hub View EXEL Investment Forum News - Investor Hub
Yahoo View EXEL Stock Mentions - Yahoo! Message Board Seeking Alpha View EXEL Stock Mentions - Seeking Alpha


Financial & Transaction Holdings

SECform4 View Insider Transactions for EXEL - SECform4.com Insider Cow View Insider Transactions for EXEL - Insider Cow
CNBC View EXEL Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for EXEL - OTC Markets
Yahoo View Insider Transactions for EXEL - Yahoo! Finance NASDAQ View Institutional Holdings for EXEL - NASDAQ


Stock Charts

FinViz View EXEL Stock Insight & Charts - FinViz.com StockCharts View EXEL Investment Charts - StockCharts.com
BarChart View EXEL Stock Overview & Charts - BarChart Trading View View EXEL User Generated Charts - Trading View




Latest Financial News for EXEL


3 Top Biotech Stocks to Buy Right Now
Posted on Sunday September 23, 2018

These biotech stocks are profitable and poised to deliver nice gains for patient investors.


The Daily Biotech Pulse: Exelixis Liver Cancer Drug On Track For European Approval, Medtronic Goes Shopping, Opiant Snags BARDA Funding
Posted on Friday September 21, 2018

The following is a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks that hit 52-week highs Sept. 20.) Abbott Laboratories (NYSE: ABT ) Acceleron ...


Exelixis’ Partner Ipsen Announces Positive CHMP Opinion for CABOMETYX® (cabozantinib) Tablets for Previously Treated Hepatocellular Carcinoma
Posted on Thursday September 20, 2018

– In the phase 3 pivotal CELESTIAL trial, CABOMETYX demonstrated a statistically significant and clinically meaningful overall survival benefit –


Exelixis' Partner Ipsen Gets Approval for Cabometyx in Canada
Posted on Thursday September 20, 2018

Exelixis (EXEL) and partner Ipsen Biopharmaceuticals Canada gain approval for Cabometyx from Health Canada for the treatment of advanced renal cell carcinoma in adult patients.


Stock Market & Investing Books

Enter a stock symbol to view the stock details.